RLAY — Relay Therapeutics Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Relay Therapeutics Inc (RLAY), worth $44.92M combined. Over the quarter 3 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $33.47M | 0.09% | NEW |
| Duquesne | $6.53M | 0.15% | NEW |
| Renaissance | $3.60M | 0.00% | -71.4% |
| Persistent | $1.32M | 0.42% | +332.2% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.